Charles River Laboratories International, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $192.0M | $191.8M | $213.8M | $207.1M | $182.8M | $229.4M | $194.6M | $210.2M |
| Accounts Receivable | $711.8M | $700.3M | $708.9M | $734.5M | $767.6M | $756.6M | $720.9M | $754.2M |
| Inventory | $346.3M | $359.7M | $299.1M | $302.6M | $279.6M | $290.2M | $278.5M | $336.2M |
| Total Current Assets | $1.53B | $1.49B | $1.45B | $1.53B | $1.47B | $1.51B | $1.40B | $1.49B |
| Property, Plant & Equipment | $1.49B | $1.51B | $1.66B | $1.59B | $1.61B | $1.59B | $1.60B | — |
| Goodwill | $3.08B | $3.04B | $2.76B | $2.92B | $2.94B | $2.87B | $2.85B | $3.12B |
| Intangible Assets (Excl. Goodwill) | $253.2M | $249.0M | $340.0M | $571.1M | $602.5M | $655.7M | $723.4M | $778.5M |
| Total Assets | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B |
| Liabilities | ||||||||
| Accounts Payable | $141.0M | $134.0M | $148.8M | $169.6M | $145.8M | $149.3M | $140.3M | $136.0M |
| Total Current Liabilities | $1.13B | $1.09B | $1.12B | $1.12B | $1.08B | $1.05B | $994.1M | $1.01B |
| Long-Term Debt | $2.62B | $2.66B | $2.14B | $2.19B | $2.33B | $2.51B | $2.24B | $2.33B |
| Total Liabilities | $4.64B | $4.74B | $3.92B | $4.06B | $4.16B | $4.34B | $4.02B | $4.18B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $1.37B | $1.37B | $1.39B | $1.94B | $1.89B | $1.84B | $1.81B | $2.12B |
| Total Stockholders' Equity | $2.84B | $2.94B | $3.16B | $3.41B | $3.35B | $3.19B | $3.46B | $3.78B |